0

Genzyme Pompe Program Update – FDA Approves Lumizyme

Author: 
Genzyme
Category: Archive
Published
May 26, 2010

On May 24, 2010 the Food and Drug Administration (FDA) approved Lumizyme for treatment of “patients 8 years and older with late (non-infantile) onset Pompe disease who do not have evidence of cardiac hypertrophy.”

For more information on the approval, and how to access treatment please read
Genzyme’s Pompe Program Update (PDF, 100 kB)

Back to news articles